| Literature DB >> 26303023 |
Janni L Sporrborn1, Gertrud B Knudsen2, Mette Sølling3, Karina Seierøe4, Annette Farre5, Bjarne Ø Lindhardt6, Thomas Benfield7, Christian T Brandt8.
Abstract
BACKGROUND: Experimental studies suggest that changes in brain ventricle size are key events in bacterial meningitis. This study investigated the relationship between ventricle size, clinical condition and risk of poor outcome in patients with bacterial meningitis.Entities:
Mesh:
Year: 2015 PMID: 26303023 PMCID: PMC4547431 DOI: 10.1186/s12879-015-1097-3
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Characteristics of 81 patients with acute bacterial meningitis and CT imaging within 24 h of diagnosis according to 30-day survival
| All | Survivors | Non-survivors |
| |
|---|---|---|---|---|
|
|
|
| ||
| Age, years | 64 (52–74) | 62 (51–68) | 73 (54–84) | 0.006 |
| Sex | 0.059 | |||
| Male, % | 44 (54 %) | 34 (62 %) | 10 (38 %) | |
| Female, % | 37 (46 %) | 21 (38 %) | 16 (62 %) | |
| Etiology | 0.23 | |||
| Streptococcus pneumoniae | 43 (53 %) | 28 (51 %) | 15 (58 %) | |
| Streptococcus sp. | 6 (7 %) | 2 (4 %) | 4 (15 %) | |
| Staphylococcus aureus | 4 (5 %) | 3 (5 %) | 1 (4 %) | |
| Listeria monocytogenes | 2 (3 %) | 1 (2 %) | 1 (4 %) | |
| Unknown | 21 (26 %) | 16 (29 %) | 5 (19 %) | |
| Other | 5 (6 %) | 5 (9 %) | 0 (0 %) | |
| Adjuvant steroid, % | 0.08 | |||
| No | 28 (35 %) | 15 (27 %) | 13 (50 %) | |
| Yes | 52 (65 %) | 39 (71 %) | 13 (50 %) | |
| Comorbidity | 0.39 | |||
| None | 51 (63 %) | 32 (58 %) | 19 (73 %) | |
| Alcoholism | 13 (16 %) | 8 (15 %) | 5 (19 %) | |
| Malignancy | 5 (6 %) | 5 (9 %) | 0 (0 %) | |
| Diabetes mellitus | 5 (6 %) | 4 (7 %) | 1 (4 %) | |
| Asplenia | 4 (5 %) | 4 (7 %) | 0 (0 %) | |
| Other immunosupp | 1 (1 %) | 1 (2 %) | 0 (0 %) | |
| Other | 2 (3 %) | 1 (2 %) | 1 (4 %) | |
| Change in mental status, % | 61 (82 %) | 39 (71 %) | 22 (85 %) | 0.20 |
| Focal neurologic deficit, % | 17 (24 %) | 15 (27 %) | 2 (8 %) | 0.07 |
| Seizures, % | 5 (7 %) | 4 (7 %) | 1 (4 %) | 1.0 |
| Temperature, ° C, | 38.9 (37.9-39.5) | 38.8 (37.7-39.4) | 39.0 (38.0-39.5) | 0.49 |
| MAP, mmHg, | 102 (88–110) | 103 (92–112) | 94 (77–109) | 0.18 |
| White Blood Cell Count, 109/L, | 17.1 (12.1-22.6) | 17.9 (12.5-24.0) | 15.7 (11.9-22.9) | 0.29 |
| Plasma C-reactive Protein, mg/L | 227 (144–337) | 238 (151–334) | 192 (87–369) | 0.51 |
| CSF-leukocytes | 2182 (523–6188) | 1932 (488–5150) | 2826 (561–7930) | 0.43 |
| CSF-protein, | 4.9 (2.5-7.8) | 3.3 (2.1-6.2) | 6.3 (5.1-11.2) | 0.001 |
| CSF-glucose, | 1.5 (0.1-2.9) | 1.4 (0.1-3.3) | 1.5 (0.1-2.4) | 0.40 |
| VBR | 0.10 (0.07-0.14) | 0.09 (0.07-0.13) | 0.13 (0.10-0.15) | 0.005 |
| VBR | 0.005 | |||
| <0.08 | 27 (33 %) | 24 (44 %) | 3 (11 %) | |
| 0.08-1.2 | 25 (31 %) | 17 (31 %) | 8 (31 %) | |
| >0.12 | 29 (36 %) | 14 (25 %) | 15 (58 %) |
MAP mean arterial pressure, CSF cerebrospinal fluid, VBR ventricle to brain ratio
Pathological ventricle to brain ratio and outcome
| CT scan performed within 24 h of diagnosis ( | Pathological VBR* | Normal VBR** |
| |
|---|---|---|---|---|
| All age groups | No | 28 % ( | 72 % ( | |
| GOS 1 | 56.5 % ( | 31.0 % ( | 0.033 | |
| GOS 5 | 34.8 % ( | 34.5 % ( | 0.98 | |
| <70 years | No | 33 % ( | 67 % ( | |
| GOS 1 | 53.0 % ( | 14.3 % ( | 0.003 | |
| GOS 5 | 35.3 % (6/17) | 42.9 % ( | 0.66 | |
| All CT scans performed during admission ( | ||||
| All age groups | No | 28.0 % ( | 72.0 % ( | |
| GOS 1 | 50.0 % ( | 32.5 % ( | 0.12 | |
| GOS 5 | 26.7 % ( | 37.7 % ( | 0.37 | |
| <70 years | No | 29.6 % ( | 70.4 % ( | |
| GOS 1 | 52.4 % ( | 16.0 % ( | 0.003 | |
| GOS 5 | 28.6 % ( | 48.0 % ( | 0.19 | |
VBR ventricle to Brain Ratio, GOS Glasgow outcome scale
* −/+ 2SD from control group mean VBR for age
** Within 2SD of control group mean VBR for age
Fig. 1a Distribution of Ventricle to Brain Ratio in age groups. Patients (scatter plot) and controls (box and whiskers with box showing median and quartiles and whiskers min. and max.). Horizontal lines indicate VBR-tertiles used for multivariate analysis. b Examples of Ventricle to Brain Ratio in patients with bacterial meningitis. Normal range VBR (left) and VBR increased > 2SD (right) within each age interval
Fig. 2Survival from bacterial meningitis according to Ventricle to Brain Ratio. Log-rank test: P = 0.004
Multivariate analysis of predictors of 30-day mortality from acute bacterial meningitis
| Multivariate model 1 | Multivariate model 2 | ||||
|---|---|---|---|---|---|
| Unadjusted MRR (95 % CI) | Adjusted MRR (95 % CI) | P-value | Adjusted MRR (95 % CI) |
| |
| Age, per year increment | 1.05 (1.01-1.08) | 1.03 (0.99-1.06) | 0.17 | 0.99 (0.95-1.04) | 0.66 |
| Sex | |||||
| Male | 1.0 | 1.0 | 1.0 | ||
| Female | 2.31 (1.05-5.10) | 2.30 (0.99-5.29) | 0.051 | 2.77 (0.96-8.00) | 0.061 |
| VBR | 0.036 | 0.029 | |||
| <0.08 | 1.0 | 1.0 | 1.0 | ||
| 0.08-0.12 | 3.12 (0.83-11.75) | 2.81 (0.70-11.28) | 0.15 | 5.18 (0.88-30.53) | 0.07 |
| >0.12 | 5.97 (1.72-20.65) | 6.03 (1.61-22.64) | 0.008 | 8.78 (1.74-44.36) | 0.009 |
| Glucocorticosteroid | |||||
| No | 1.0 | 1.0 | 1.0 | ||
| Yes | 0.47 (0.22-1.01) | 0.44 (0.19-1.03) | 0.057 | 0.62 (0.20-1.96) | 0.42 |
| CSF-protein per g/L increment, | 1.17 (1.07-1.28) | - | 1.17 (1.04-1.31) | 0.008 |
MRR mortality rate ratio, CI confidence interval, VBR ventricle to brain ratio, CSF cerebrospinal fluid